RxDoctor Payments Data

Lauren Martin, PA

Physician Assistant · Tullahoma, TNNPI 1851546469

Payments from drug & device makers

$7,777in general payments, 2019–2025

Across 555 payments — averaging $14.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$914
  • Amgen$796
  • Pfizer$452
  • AstraZeneca$417
  • AbbVie$386
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$7,763100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,777 in reported general payments places this provider in the 90th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$68,580
Medicare patients
197
Services billed
2,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$77,076
MounjaroTirzepatide47$56,616
EliquisApixaban46$47,226
JardianceEmpagliflozin36$43,668
RybelsusSemaglutide21$27,259
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$26,455
LinzessLinaclotide21$24,495
Tresiba Flextouch U-200Insulin Degludec30$23,135
TrulicityDulaglutide20$19,219
Tresiba Flextouch U-100Insulin Degludec14$13,623
Janumet XrSitagliptin Phos/Metformin Hcl15$10,869
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$8,021
BelsomraSuvorexant11$5,306
Dexlansoprazole DrDexlansoprazole17$5,199
Clonidine20$2,613

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,208$104,33583 claims
Lilly USA, LLCMounjaro, Trulicity$914$75,83567 claims
PfizerEliquis$452$47,22646 claims
Boehringer IngelheimJardiance$238$43,66836 claims
GSKTrelegy Ellipta$216$26,45515 claims
AbbVieLinzess, Synthroid$386$25,30637 claims
MerckJanumet Xr, Belsomra$118$16,17526 claims
AstraZenecaBreztri Aerosphere$417$8,02111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Tullahoma

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →